Survival after breast-conserving surgery versus mastectomy in mammary Paget disease: A propensity-matched SEER population-based analysis
Biomolecules and Biomedicine · 01.07.2026
DOI: 10.17305/bb.2026.14512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 01.07.2026. Verfasst von İsmail Zİhnİ und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Akdeniz University Medical Faculty, Antalya, Türkiye. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mastectomy has traditionally been the dominant surgical approach for mammary Paget disease, but its survival advantage over breast-conserving surgery (BCS) remains uncertain. We compared breast cancer-specific survival (BCSS) and overall survival (OS) after mastectomy versus BCS in a population-based SEER cohort. Female patients with mammary Paget disease diagnosed between 2000 and 2022 were identified; after exclusions, 641 surgically treated patients were included, of whom 323 underwent BCS and 318 underwent mastectomy. The primary treatment-strategy effect was estimated using inverse-probability-of-treatment weighting, with radiotherapy excluded from the propensity model as a mediator on the BCS pathway. A 1:1 propensity-matched cohort served as a sensitivity analysis. Survival was assessed using Kaplan–Meier analysis, multivariable Cox regression, Aalen–Johansen competing-risk estimation, Fine–Gray modelling, and additional robustness analyses. After matching, 228 pairs were analyzed. Five-year BCSS was 95.8% after BCS and 94.1% after mastectomy; corresponding ten-year estimates were 93.4% and 92.2% (log-rank p = 0.72). Ten-year cumulative incidence of breast cancer-specific death was 6.3% versus 7.4%, respectively, after accounting for competing non-cancer mortality. OS did not differ significantly between groups (p = 0.46). Mastectomy was not associated with improved BCSS in the primary weighted analysis (hazard ratio 1.19, 95% confidence interval 0.66–2.14, p = 0.56) or the matched sensitivity analysis (hazard ratio 1.30, 95% confidence interval 0.58–2.88, p = 0.52). Findings were concordant across competing-risk, overlap-weighted, parsimonious, penalized, and age-stratified models. In this SEER-based, propensity-adjusted analysis, mastectomy was not associated with a detectable survival advantage over BCS in women with mammary Paget disease. These findings support BCS as a reasonable option in selected patients, while prospective studies incorporating margin status, receptor biology, local recurrence, and patient-reported outcomes are needed.
Autor:innen und Institutionen
- Department of General Surgery, Akdeniz University Medical Faculty, Antalya, Türkiye.
Zitieren
APA
Zİhnİ, İ., & Sabuncuoğlu, M. Z. (2026). Survival after breast-conserving surgery versus mastectomy in mammary Paget disease: A propensity-matched SEER population-based analysis. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2026.14512
Vancouver
Zİhnİ İ, Sabuncuoğlu MZ. Survival after breast-conserving surgery versus mastectomy in mammary Paget disease: A propensity-matched SEER population-based analysis. Biomolecules and Biomedicine. 2026. doi:10.17305/bb.2026.14512
BibTeX
@article{Zhn2026,
author = {Zİhnİ, İsmail and Sabuncuoğlu, Mehmet Zafer},
title = {Survival after breast-conserving surgery versus mastectomy in mammary Paget disease: A propensity-matched SEER population-based analysis},
journal = {Biomolecules and Biomedicine},
year = {2026},
doi = {10.17305/bb.2026.14512}
}
EUVIMED